Company Number: NI678090

Analysis Date: 2025-07-29 17:39 UTC

Financial Health Assessment for MOIRA OSTEOPATHY LTD (NI678090)

---

1. Financial Health Score: B-

Explanation:
MOIRA OSTEOPATHY LTD shows improving financial health over recent years with positive net current assets and shareholders' funds in the latest financial year. However, the company remains relatively small with limited equity and modest liquidity buffers, which suggests a cautious outlook. The absence of audit and relatively small scale operations reflect typical conditions for a micro/small service business, but the steady recovery from prior negative net assets signals improving vitality. The grade B- reflects a cautious but positive diagnosis with room for strengthening capital and cash flow resilience.

---

2. Key Vital Signs

Metric	2024 (£)	2023 (£)	Interpretation
Cash at Bank	4,545	1,829	Healthy increase in cash reserves; good liquidity signal
Current Liabilities	3,592	1,957	Increased short-term obligations; manageable relative to cash
Net Current Assets (Working Capital)	953	(128)	Positive working capital signals improved short-term financial health; current assets exceed liabilities
Shareholders' Funds (Equity)	953	(128)	Turned positive after previous loss position; equity base is small but improving
Number of Employees	2	3	Small workforce consistent with micro business; manageable payroll costs

Interpretation:

• Liquidity is improving, with cash balances more than doubling year-over-year. This resembles a "healthy pulse" indicating the company can cover its immediate obligations without distress.
• Working capital shifted from negative to positive, an important symptom of operational recovery. Positive working capital suggests the company can meet short-term debts comfortably.
• Shareholders' funds have turned positive after previously being negative, indicating the company is moving out of a deficit "anemic" financial state toward better capital health.
• However, the small equity base and increased current liabilities require ongoing monitoring and careful management to avoid cash crunches.

---

3. Diagnosis: Financial Condition Overview

MOIRA OSTEOPATHY LTD exhibits signs of financial recovery and stabilization after early losses. The negative equity and working capital in 2022 were symptoms of financial distress, likely reflecting start-up challenges or early operating losses. The latest accounts to April 2024 show a reversal with positive retained earnings, net current assets, and cash balances, suggesting the company is regaining financial strength.

The business operates in "Other human health activities," a sector typically characterized by steady demand but requiring careful cash flow management due to small scale operations and limited capital. The increase in current liabilities, particularly taxation and social security, indicates normal operational expenses and obligations, but these remain manageable given the improved liquidity.

The directors have complied with small companies’ reporting exemptions, meaning the accounts are unaudited; this is common for micro/small companies but means external assurance is limited.

Overall, the company is in a stable but cautious position—no immediate symptoms of distress, yet still vulnerable due to modest financial buffers and scale.

---

4. Recommendations: Actions to Improve Financial Wellness

1. Enhance Cash Flow Management:
   Continue building cash reserves to strengthen liquidity "heart rate." Monitor receivables and payables closely to avoid cash flow gaps.

2. Build Equity Base:
   Consider retaining more profits or injecting additional capital to increase shareholder funds. A stronger equity base acts like a "robust immune system" to weather economic shocks.

3. Control Costs and Liabilities:
   Keep current liabilities under control, especially tax and social security payments. Negotiate payment terms if needed to smooth cash outflows.

4. Regular Financial Review:
   Implement quarterly financial check-ups to detect any early "symptoms" of financial strain and enable timely corrective action.

5. Consider Audit or External Review:
   While not required, an independent review could provide reassurance to stakeholders and identify hidden risks or opportunities.

---